Precision diagnosis and treatment study for liver cancer
Part of Cancer, Digestive system clinical trials.
This study aims to improve how doctors diagnose and treat liver cancer by combining advanced imaging tests and genetic analysis. It may help in choosing the most effective treatment for each person.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 70 years old.
- You must have been diagnosed with either hepatocellular carcinoma (HCC) or intrahepatic cholangiocarcinoma (ICC), two types of liver cancer.
- You must be scheduled to have surgery or conversion therapy (treatment to make surgery possible).
- The liver tumor must be confirmed by a biopsy or after surgery.
- The tumor must be located no deeper than 8 cm (about 3 inches) from the skin surface.
- You must be able to hold your breath during imaging exams.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at blood and tissue samples from people with liver cancer to find markers that can predict how well treatment works and whether the cancer might come back. It may help doctors personalize treatment and follow-up care.
This study compares two imaging methods, ultrasound and MRI, to see which is better at finding liver cancer early in people who are at high risk. Early detection could lead to more effective treatment and better outcomes.
This study uses advanced imaging (MRI and contrast-enhanced ultrasound) with computer technology to help doctors decide the best treatment for early-stage liver cancer. It aims to improve outcomes for patients who undergo surgery or microwave ablation.
This study tests a new, more detailed ultrasound technique to better see liver tumors. It may help doctors understand your tumor better without extra procedures.
This study tracks how bile duct and liver cancers change during treatment, to help doctors find the best therapies for patients. It is for people who are newly diagnosed or starting a new treatment.
This trial tests a new imaging technique that uses a special dye combined with a chemotherapy drug to help surgeons see and remove liver cancer more precisely during surgery. It is for people with a first-time, single liver tumor that is small and can be surgically removed.
Hear when a new Hepatocellular Carcinoma (HCC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.